Terns Pharmaceuticals's total assets for Q3 2024 were $378.23M, an increase of 63.82% from the previous quarter. TERN total liabilities were $13.76M for the fiscal quarter, a 12.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.